Annual FCF
$217.41 M
-$281.61 M-56.43%
March 31, 2024
Summary
- As of February 6, 2025, RDY annual free cash flow is $217.41 million, with the most recent change of -$281.61 million (-56.43%) on March 31, 2024.
- During the last 3 years, RDY annual FCF has fallen by -$93.75 million (-30.13%).
- RDY annual FCF is now -56.43% below its all-time high of $499.02 million, reached on March 31, 2023.
Performance
RDY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$26.38 M
-$43.07 M-258.03%
December 31, 2024
Summary
- As of February 6, 2025, RDY quarterly free cash flow is -$26.38 million, with the most recent change of -$43.07 million (-258.03%) on December 31, 2024.
- RDY quarterly FCF is now -110.80% below its all-time high of $244.12 million, reached on December 31, 2022.
Performance
RDY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$54.46 M
-$21.61 M-28.41%
December 31, 2024
Summary
- As of February 6, 2025, RDY TTM free cash flow is $54.46 million, with the most recent change of -$21.61 million (-28.41%) on December 31, 2024.
- RDY TTM FCF is now -91.04% below its all-time high of $607.94 million, reached on September 30, 2023.
Performance
RDY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RDY Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -56.4% | - | - |
| 3 y3 years | -30.1% | - | - |
| 5 y5 years | -25.2% | -132.5% | -86.3% |
RDY Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.4% | +78.8% | -110.8% | at low | -91.0% | at low |
| 5 y | 5-year | -56.4% | +78.8% | -110.8% | +71.3% | -91.0% | +400.6% |
| alltime | all time | -56.4% | +174.9% | -110.8% | +92.7% | -91.0% | +116.9% |
Dr Reddys Laboratories Limited Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$26.38 M(-258.0%) | $54.46 M(-28.4%) |
| Sep 2024 | - | $16.69 M(-74.0%) | $76.08 M(-65.0%) |
| Mar 2024 | $217.41 M(-56.4%) | $64.15 M(-1447.1%) | $217.41 M(-39.5%) |
| Dec 2023 | - | -$4.76 M(-102.8%) | $359.06 M(-40.9%) |
| Sep 2023 | - | $169.23 M(-1609.6%) | $607.94 M(+18.2%) |
| Jun 2023 | - | -$11.21 M(-105.4%) | $514.18 M(+3.0%) |
| Mar 2023 | $499.02 M(+310.3%) | $205.80 M(-15.7%) | $499.02 M(+37.9%) |
| Dec 2022 | - | $244.12 M(+223.4%) | $361.90 M(+24.5%) |
| Sep 2022 | - | $75.47 M(-386.1%) | $290.69 M(+55.3%) |
| Jun 2022 | - | -$26.38 M(-138.4%) | $187.24 M(+54.0%) |
| Mar 2022 | $121.61 M(-60.9%) | $68.69 M(-60.3%) | $121.61 M(-24.1%) |
| Dec 2021 | - | $172.90 M(-718.1%) | $160.20 M(-984.2%) |
| Sep 2021 | - | -$27.97 M(-69.6%) | -$18.12 M(-118.0%) |
| Jun 2021 | - | -$92.00 M(-185.8%) | $100.74 M(-67.6%) |
| Mar 2021 | $311.16 M(-6.9%) | $107.28 M(-2079.2%) | $311.16 M(+47.1%) |
| Dec 2020 | - | -$5.42 M(-106.0%) | $211.52 M(-29.0%) |
| Sep 2020 | - | $90.88 M(-23.3%) | $298.09 M(-10.2%) |
| Jun 2020 | - | $118.42 M(+1449.9%) | $332.05 M(-0.6%) |
| Mar 2020 | $334.10 M(+15.0%) | $7.64 M(-90.6%) | $334.10 M(-16.0%) |
| Dec 2019 | - | $81.15 M(-35.0%) | $397.80 M(-23.2%) |
| Sep 2019 | - | $124.84 M(+3.6%) | $517.92 M(-1.1%) |
| Jun 2019 | - | $120.47 M(+68.9%) | $523.45 M(+80.1%) |
| Mar 2019 | $290.59 M(+168.2%) | $71.34 M(-64.6%) | $290.59 M(+2.5%) |
| Dec 2018 | - | $201.27 M(+54.4%) | $283.53 M(+92.9%) |
| Sep 2018 | - | $130.38 M(-216.0%) | $147.00 M(+111.9%) |
| Jun 2018 | - | -$112.39 M(-274.9%) | $69.37 M(-36.0%) |
| Mar 2018 | $108.36 M(-137.3%) | $64.28 M(-0.7%) | $108.36 M(-9.1%) |
| Dec 2017 | - | $64.74 M(+22.8%) | $119.22 M(+34.1%) |
| Sep 2017 | - | $52.74 M(-171.9%) | $88.91 M(-127.5%) |
| Jun 2017 | - | -$73.40 M(-197.7%) | -$322.77 M(+11.2%) |
| Mar 2017 | -$290.36 M(-172.0%) | $75.14 M(+118.2%) | -$290.36 M(+5.2%) |
| Dec 2016 | - | $34.43 M(-109.6%) | -$276.00 M(+34.7%) |
| Sep 2016 | - | -$358.94 M(+775.5%) | -$204.96 M(-175.7%) |
| Jun 2016 | - | -$41.00 M(-145.8%) | $270.69 M(-32.9%) |
| Mar 2016 | $403.14 M(+153.9%) | $89.50 M(-15.1%) | $403.14 M(-7.8%) |
| Dec 2015 | - | $105.47 M(-9.6%) | $437.17 M(+48.7%) |
| Sep 2015 | - | $116.72 M(+27.6%) | $293.96 M(+39.1%) |
| Jun 2015 | - | $91.45 M(-26.0%) | $211.32 M(+33.1%) |
| Mar 2015 | $158.78 M(+8.3%) | $123.53 M(-427.3%) | $158.78 M(+16.5%) |
| Dec 2014 | - | -$37.74 M(-210.8%) | $136.27 M(-40.5%) |
| Sep 2014 | - | $34.07 M(-12.5%) | $228.86 M(+60.6%) |
| Jun 2014 | - | $38.92 M(-61.5%) | $142.52 M(-2.8%) |
| Mar 2014 | $146.64 M(+33.3%) | $101.01 M(+84.1%) | $146.64 M(+166.0%) |
| Dec 2013 | - | $54.86 M(-204.9%) | $55.14 M(+51.7%) |
| Sep 2013 | - | -$52.27 M(-221.4%) | $36.35 M(-68.7%) |
| Jun 2013 | - | $43.05 M(+353.0%) | $116.31 M(+5.7%) |
| Mar 2013 | $110.05 M | $9.50 M(-73.7%) | $110.05 M(-47.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | $36.08 M(+30.3%) | $208.64 M(-15.1%) |
| Sep 2012 | - | $27.68 M(-24.8%) | $245.63 M(+18.7%) |
| Jun 2012 | - | $36.78 M(-66.0%) | $206.90 M(+30.5%) |
| Mar 2012 | $158.54 M(-300.7%) | $108.10 M(+47.9%) | $158.54 M(+783.6%) |
| Dec 2011 | - | $73.07 M(-760.8%) | $17.94 M(-121.0%) |
| Sep 2011 | - | -$11.06 M(-4.5%) | -$85.34 M(+25.9%) |
| Jun 2011 | - | -$11.57 M(-64.4%) | -$67.80 M(-14.2%) |
| Mar 2011 | -$79.01 M(-141.8%) | -$32.50 M(+7.6%) | -$79.01 M(+50.6%) |
| Dec 2010 | - | -$30.21 M(-565.9%) | -$52.45 M(-316.0%) |
| Sep 2010 | - | $6.48 M(-128.5%) | $24.28 M(-72.0%) |
| Jun 2010 | - | -$22.78 M(+283.9%) | $86.80 M(-54.0%) |
| Mar 2010 | $188.81 M(-3484.9%) | -$5.94 M(-112.8%) | $188.81 M(-34.0%) |
| Dec 2009 | - | $46.51 M(-32.6%) | $286.20 M(+35.6%) |
| Sep 2009 | - | $69.00 M(-12.9%) | $211.09 M(+147.7%) |
| Jun 2009 | - | $79.23 M(-13.4%) | $85.23 M(-1627.9%) |
| Mar 2009 | -$5.58 M(+42.4%) | $91.45 M(-419.8%) | -$5.58 M(-93.6%) |
| Dec 2008 | - | -$28.60 M(-49.7%) | -$86.91 M(+32.2%) |
| Sep 2008 | - | -$56.86 M(+391.4%) | -$65.75 M(+39.3%) |
| Jun 2008 | - | -$11.57 M(-214.3%) | -$47.19 M(+1104.4%) |
| Mar 2008 | -$3.92 M(-102.5%) | $10.12 M(-236.1%) | -$3.92 M(-105.3%) |
| Dec 2007 | - | -$7.44 M(-80.6%) | $74.25 M(-45.7%) |
| Sep 2007 | - | -$38.30 M(-220.8%) | $136.77 M(-40.4%) |
| Jun 2007 | - | $31.70 M(-64.1%) | $229.62 M(+46.0%) |
| Mar 2007 | $157.24 M(-2647.6%) | $88.29 M(+60.3%) | $157.24 M(+168.8%) |
| Dec 2006 | - | $55.09 M(+1.0%) | $58.49 M(+460.5%) |
| Sep 2006 | - | $54.54 M(-234.1%) | $10.43 M(-123.3%) |
| Jun 2006 | - | -$40.68 M(+288.9%) | -$44.72 M(+624.6%) |
| Mar 2006 | -$6.17 M(-150.9%) | -$10.46 M(-248.8%) | -$6.17 M(-114.8%) |
| Dec 2005 | - | $7.03 M(-1244.5%) | $41.60 M(+125.4%) |
| Sep 2005 | - | -$614.50 K(-71.1%) | $18.46 M(+14.3%) |
| Jun 2005 | - | -$2.13 M(-105.7%) | $16.15 M(+33.3%) |
| Mar 2005 | $12.11 M(-64.9%) | $37.31 M(-331.6%) | $12.11 M(-182.8%) |
| Dec 2004 | - | -$16.11 M(+451.6%) | -$14.63 M(-271.1%) |
| Sep 2004 | - | -$2.92 M(-52.6%) | $8.55 M(-57.8%) |
| Jun 2004 | - | -$6.17 M(-158.3%) | $20.27 M(-41.3%) |
| Mar 2004 | $34.56 M(-41.1%) | $10.57 M(+49.5%) | $34.56 M(+7.3%) |
| Dec 2003 | - | $7.07 M(-19.7%) | $32.21 M(-9.5%) |
| Sep 2003 | - | $8.80 M(+8.5%) | $35.59 M(+0.1%) |
| Jun 2003 | - | $8.12 M(-1.2%) | $35.55 M(-39.4%) |
| Mar 2003 | $58.70 M(-21.2%) | $8.22 M(-21.4%) | $58.70 M(-26.8%) |
| Dec 2002 | - | $10.45 M(+19.3%) | $80.16 M(-23.3%) |
| Sep 2002 | - | $8.76 M(-72.0%) | $104.55 M(+5.8%) |
| Jun 2002 | - | $31.27 M(+5.4%) | $98.83 M(+32.7%) |
| Mar 2002 | $74.50 M(+2568.2%) | $29.67 M(-14.8%) | $74.50 M(+66.2%) |
| Dec 2001 | - | $34.84 M(+1044.3%) | $44.83 M(+348.8%) |
| Sep 2001 | - | $3.04 M(-56.2%) | $9.99 M(+43.8%) |
| Jun 2001 | - | $6.94 M | $6.94 M |
| Mar 2001 | $2.79 M | - | - |
FAQ
- What is Dr Reddys Laboratories Limited annual free cash flow?
- What is the all time high annual FCF for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual FCF year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited TTM free cash flow?
- What is the all time high TTM FCF for Dr Reddys Laboratories Limited?
What is Dr Reddys Laboratories Limited annual free cash flow?
The current annual FCF of RDY is $217.41 M
What is the all time high annual FCF for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual free cash flow is $499.02 M
What is Dr Reddys Laboratories Limited annual FCF year-on-year change?
Over the past year, RDY annual free cash flow has changed by -$281.61 M (-56.43%)
What is Dr Reddys Laboratories Limited quarterly free cash flow?
The current quarterly FCF of RDY is -$26.38 M
What is the all time high quarterly FCF for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly free cash flow is $244.12 M
What is Dr Reddys Laboratories Limited TTM free cash flow?
The current TTM FCF of RDY is $54.46 M
What is the all time high TTM FCF for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high TTM free cash flow is $607.94 M